Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2018
- Source ID
- 10.1016/j.bbmt.2017.09.013
Entities
People
- Amer Beitinjaneh
- Bipin N Savani
- Brent R. Logan
- Bronwen E Shaw
- Christopher N. Bredeson
- David F. Stroncek
- Deidre M. Kiefer
- Dennis L Confer
- Dipnarine Maharaj
- Galen E Switzer
- Gregory A. Hale
- Hillard M Lazarus
- Hisham Abdel-azim
- Ibrahim Ahmed
- Jane L. Liesveld
- Jean A. Yared
- Jeffrey Szer
- Joerg Halter
- Kimberly Anne Kasow
- Matthew Seftel
- Michael A Pulsipher
- Miguel Angel Diaz
- Nirali Shah
- Paolo Anderlini
- Pashna N Munshi
- Paul V. O'donnell
- Peiman Hematti
- Pintip Chitphakdithai
- Richard F. Olsson
- Sachiko Seo
- Siddhartha Ganguly
- Zachariah DeFilipp
- Zheng Zhou
Organizations
- Amgen
- Angiocrine Bioscience (United States)
- Astellas Pharma (United States)
- AstraZeneca (United States)
- Atara Biotherapeutics, Inc.
- Bristol-Myers Squibb
- Celgene
- Chiron Corporation
- Fred Hutchinson Cancer Center
- Genzyme
- Gilead Sciences
- Health Resources and Services Administration
- Incyte
- Janssen Scientific Affairs (United States)
- Jazz Pharmaceuticals
- Karyopharm Therapeutics (United States)
- Kite Pharma
- Medical College of Wisconsin
- Merck & Co.
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Otsuka Pharmaceutical
- Patient-Centered Outcomes Research Institute
- Pfizer
- Seagen
- Shire plc
- Spectrum Pharmaceuticals
- St. Baldrick's Foundation
- Swedish Orphan Biovitrum
- Takeda Oncology
- University of Minnesota